# Survodutide phase 2 trial: weight loss at 46 weeks

Source: https://pepvault.app/research/survodutide-le-roux-2024

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Survodutide](https://pepvault.app/research#survodutide)

Randomized trial · people

# Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this phase 2 trial, survodutide lowered bodyweight more than placebo at every dose tested, with larger losses at higher doses and gut side effects in most people taking it.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 387
- **Published:** 2024
- **Journal:** Lancet Diabetes Endocrinol

## What they tested

The team tested how safe and well tolerated survodutide was for obesity management, and how much bodyweight it took off at different doses.

## How the study was done

A randomized, double-blind, placebo-controlled phase 2 trial in 387 adults aged 18 to 75 with a BMI of 27 kg/m2 or more and no diabetes, at 43 centers in 12 countries. People got once-weekly shots of survodutide (0.6, 2.4, 3.6 or 4.8 mg) or placebo (a dummy shot) for 46 weeks: 20 weeks of dose increases, then 26 weeks at the set dose.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking survodutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Average bodyweight change at week 46 was -6.2% in the 0.6 mg arm, -12.5% in the 2.4 mg arm, -13.2% in the 3.6 mg arm and -14.9% in the 4.8 mg arm, compared with -2.8% on placebo. Weight loss grew with the dose. Side effects showed up in 281 of 309 (91%) people on survodutide and 58 of 77 (75%) on placebo. Most were gut-related: 232 of 309 (75%) on survodutide and 32 of 77 (42%) on placebo.

## What it doesn’t show

This was a 46-week dose-finding trial in adults without diabetes, and only 233 of 386 treated people (60.4%) finished the full treatment period. The trial was funded by Boehringer Ingelheim.

## The paper

le Roux et al. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet Diabetes Endocrinol. 2024.

- [PubMed (PMID 38330987)](https://pubmed.ncbi.nlm.nih.gov/38330987/)
- [The paper (DOI 10.1016/S2213-8587(23)00356-X)](https://doi.org/10.1016/S2213-8587%2823%2900356-X)
- [ClinicalTrials.gov (NCT04667377)](https://clinicaltrials.gov/study/NCT04667377)

## The compound

- [Survodutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)

## With this study

### Survodutide

- [Survodutide: the full reference](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/survodutide-10mg)

### Studies

- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026)
- [All 2 studies](https://pepvault.app/research#survodutide)

### Compared with

- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Survodutide

- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026) Randomized trial · people · 2026
- [Every study on Survodutide](https://pepvault.app/research#survodutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking survodutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking survodutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Survodutide

- [Survodutide: the full reference](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/survodutide-10mg)

### Studies

- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026)
- [All 2 studies](https://pepvault.app/research#survodutide)

### Compared with

- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking survodutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Survodutide](https://pepvault.app/research#survodutide)

## The library

- [Survodutide](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
